SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-21-278247
Filing Date
2021-09-21
Accepted
2021-09-21 15:37:54
Documents
3
Group Members
ALBERT CHAFHM LIFE SCIENCES VIII, L.L.C.FHM LIFE SCIENCES VIII, L.P.FHMLSP, L.L.C.FHMLSP, L.P.FRAZIER LIFE SCIENCES PUBLIC FUND L.P.JAMES BRUSHJAMES N. TOPPERPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d211869dsc13da.htm SC 13D/A 236236
2 EX-99.A d211869dex99a.htm EX-99.A 19026
3 EX-99.B d211869dex99b.htm EX-99.B 71450
  Complete submission text file 0001193125-21-278247.txt   328745
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Subject) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88896 | Film No.: 211266301
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET SUITE 3200 SEATTLE WA 98101 206-254-7200
Frazier Life Sciences VIII, L.P. (Filed by) CIK: 0001655827 (see all company filings)

IRS No.: 475290848 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A